Mostra i principali dati dell'item

dcterms.contributor.authorPalomba, Rosa
dcterms.contributor.authorMiralto, Federica
dcterms.contributor.authorVinciguerra, Annamaria
dcterms.contributor.authorSalvato, Fabiana
dcterms.contributor.authorVaccarella, Anna
dc.date.accessioned2014-06-10T09:39:52Z
dc.date.available2014-06-10T09:39:52Z
dcterms.date.issued2014
dcterms.identifier.citationPalomba R, Miralto F, Vinciguerra A, Salvato F, Vaccarella A. Combined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapy. Translational Medicine @ UniSa 2014;9(8):38-42en_US
dcterms.identifier.issn2239-9747en_US
dcterms.identifier.urihttp://hdl.handle.net/10556/1395
dcterms.identifier.urihttp://dx.doi.org/10.14273/unisa-244
dc.description.abstractThe aim of this study is the analysis of the beneficial impact of using opioid receptor antagonist associated to opioid analgesic on the quality of life in patients suffering from chronic non-cancer pain. We recruited 60 patients suffering from osteo-articular diseases who were randomized into two groups of treatment. The group A was treated with the association of opioid receptor antagonist and opioid agonist, represented by Oxycodone. The group B was treated with the opioid analgesics Oxycodone, transdermal Fentanil, and Hidromorphone, without the opioid antagonist. The end-points assessed were the duration of titration, the average reached dosage, the duration of the stability of dosage and the opioid–induced constipation (OIC) using the BFI.en_US
dcterms.format.extentP. 38-42en_US
dc.language.isoenen_US
dcterms.sourceUniSa. Sistema Bibliotecario di Ateneoen_US
dcterms.subjectOxycodone/Naloxoneen_US
dcterms.subjectChronic painen_US
dcterms.subjectChronic osteo-articular diseasesen_US
dcterms.titleCombined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapyen_US
dcterms.typeArticleen_US
 Find Full text

Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item